Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Poortvliet, Rosalinde K E ^a   Ford, Ian ^b   Lloyd, Suzanne M ^b   Sattar, Naveed ^b   Mooijaart, Simon P ^a,c   de Craen, Anton J M ^a   Westendorp, Rudi G J ^a,d   Jukema, J Wouter ^a   Packard, Christopher J ^e   Gussekloo, Jacobijn ^a   de Ruijter, Wouter ^a   Stott, David J ^e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Institute for Evidence Based Medicine in Old Age   (Netherlands)

^d Netherlands Consortium for Healthy Ageing   (Netherlands)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PRAVASTATIN;

AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GENDER; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIASTOLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PRAVASTATIN; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SYSTOLE;

EID: 84871453150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052438     Document Type: Article

References (29)

1. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, et al. (2005) Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 111: 697-716.
2. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, et al. (2005) Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23: 697-701.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252.
4. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105-1187.
5. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, et al. (2008) European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 26: 1505-1526.
6. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903-1913.
7. Klungel OH, de Boer A, Paes AH, Nagelkerke NJ, Seidell JC, et al. (2000) Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. J Clin Epidemiol 53: 1158-1163.
8. Marshall T, (2004) When measurements are misleading: modelling the effects of blood pressure misclassification in the English population. BMJ 328: 933.
9. Keenan K, Hayen A, Neal BC, Irwig L, (2009) Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. BMJ 338: b1492.
10. Rothwell PM, (2010) Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 375: 938-948.
11. Cuffe RL, Howard SC, Algra A, Warlow CP, Rothwell PM, (2006) Medium-term variability of blood pressure and potential underdiagnosis of hypertension in patients with previous transient ischemic attack or minor stroke. Stroke 37: 2776-2783.
12. Howard SC, Rothwell PM, (2003) Regression dilution of systolic and diastolic blood pressure in patients with established cerebrovascular disease. J Clin Epidemiol 56: 1084-1091.
13. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, et al. (2010) Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375: 895-905.
14. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, et al. (2011) The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 57: 160-166.
15. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360: 1623-1630.
16. Ford I, Blauw GJ, Murphy MB, Shepherd J, Cobbe SM, et al. (2002) A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics. Curr Control Trials Cardiovasc Med 3: 8.
17. Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, et al. (1999) The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol 84: 1192-1197.
18. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, et al. (2000) Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36: 901-906.
19. Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, et al. (2003) Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 21: 2251-2257.
20. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G, (1993) Prognostic value of 24-hour blood pressure variability. J Hypertens 11: 1133-1137.
21. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G, (1987) Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5: 93-98.
22. Tozawa M, Iseki K, Yoshi S, Fukiyama K, (1999) Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease. Nephrol Dial Transplant 14: 1976-1981.
23. Havlik RJ, Foley DJ, Sayer B, Masaki K, White L, et al. (2002) Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: the Honolulu-Asia Aging study. Stroke 33: 26-30.
24. Hata Y, Kimura Y, Muratani H, Fukiyama K, Kawano Y, et al. (2000) Office blood pressure variability as a predictor of brain infarction in elderly hypertensive patients. Hypertens Res 23: 553-560.
25. Hata Y, Muratani H, Kimura Y, Fukiyama K, Kawano Y, et al. (2002) Office blood pressure variability as a predictor of acute myocardial infarction in elderly patients receiving antihypertensive therapy. J Hum Hypertens 16: 141-146.
26. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, et al. (2010) Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375: 895-905.
27. Geeganage C, Tracy M, England T, Sare G, Moulin T, et al. (2011) Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 42: 491-493.
28. Grove JS, Reed DM, Yano K, Hwang LJ, (1997) Variability in systolic blood pressure-a risk factor for coronary heart disease? Am J Epidemiol 145: 771-776.
29. Webb AJ, Fischer U, Mehta Z, Rothwell PM, (2010) Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 375: 906-915.